scispace - formally typeset
H

Hongqian Guo

Researcher at Nanjing University

Publications -  287
Citations -  3826

Hongqian Guo is an academic researcher from Nanjing University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 25, co-authored 200 publications receiving 2299 citations. Previous affiliations of Hongqian Guo include Nanjing Medical University & Southeast University.

Papers
More filters
Journal ArticleDOI

O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.

TL;DR: This study demonstrated the great potential of HSA-MnO2-Ce6 NPs for bladder cancer photodynamic ablation and provided a new therapeutic strategy to overcoming tumor hypoxia and showed remarkably improved therapeutic efficacy and significantly prolonged lifetime of mice as compared with controls.
Journal ArticleDOI

Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.

TL;DR: It is found thatcircSLC8A1 was down-regulated in bladder cancer tissues and cell lines, and circSLC9A1 expression was associated with the pathological stage and histological grade of bladder cancer.
Journal ArticleDOI

TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.

TL;DR: It is proved that the dysregulated lncRNA-LET/NF90/miR-145 axis by gemcitabine-induced TGFβ1 promotes UBC chemoresistance through enhancing cancer cell stemness, and targeting this axis could be a promising therapeutic approach in treating UBC patients.
Journal ArticleDOI

Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation

TL;DR: Overall, IL- 6 trans-signaling may contribute to crucial events in the development of renal fibrosis, and the targeting of IL-6 trans-Signaling by Fc-gp130 may provide a novel therapeutic strategy for the treatment of renal Fibrosis.